Intravescical prostatic protrusion is a predictor of alpha blockers response: results from an observational study

To investigate the efficacy of tamsulosin in patients with lower urinary tract symptoms (LUTS) and benign prostatic enlargement (BPE) with intravesical prostatic protrusion (IPP). Ultrasound measurement of the IPP has been previously described as an effective instrument for the evaluation of benign...

Full description

Saved in:
Bibliographic Details
Published in:BMC urology 2018-02, Vol.18 (1), p.6-6, Article 6
Main Authors: Topazio, L, Perugia, C, De Nunzio, C, Gaziev, G, Iacovelli, V, Bianchi, D, Vespasiani, G, Finazzi Agrò, E
Format: Article
Language:English
Subjects:
Adrenergic alpha-antagonists
Adrenergic alpha-Antagonists - pharmacology
Adrenergic alpha-Antagonists - therapeutic use
Aged
Alpha-blockers
BPH
Complications and side effects
Diagnosis
Dosage and administration
Drug therapy
Humans
Intravesical prostatic protrusion
LUTS
Male
Middle Aged
Predictive Value of Tests
Prospective Studies
Prostate - diagnostic imaging
Prostate - drug effects
Prostatic diseases
Prostatic Hyperplasia - diagnostic imaging
Prostatic Hyperplasia - drug therapy
Treatment Outcome
Urinary Bladder - diagnostic imaging
Urinary tract infections
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To investigate the efficacy of tamsulosin in patients with lower urinary tract symptoms (LUTS) and benign prostatic enlargement (BPE) with intravesical prostatic protrusion (IPP). Ultrasound measurement of the IPP has been previously described as an effective instrument for the evaluation of benign prostatic obstruction (BPO) and could help in clarifying the role of alpha-blockers in patients with (BPE). Patients with BPE and LUTS were enrolled in this observational study. Intravesical prostatic protrusion was graded as grade 1 (
ISSN:1471-2490
1471-2490
DOI:10.1186/s12894-018-0320-0